Antipyrine
Cat.No:IA0390 Solarbio
CAS:60-80-0
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:GC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Immunology & Inflammation >
AntipyrineCAS:60-80-0
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:GC≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 60-80-0 |
Name | Antipyrine |
Molecular Formula | C11H12N2O |
Molecular Weight | 188.23 |
Solubility | Soluble in Water/DMSO |
Purity | GC≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 200-486-6 |
MDL | MFCD00003146 |
SMILES | O=C1N(C2=CC=CC=C2)N(C)C(C)=C1 |
InChIKey | VEQOALNAAJBPNY-UHFFFAOYSA-N |
InChI | InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3 |
PubChem CID | 2206 |
Target Point | COX-3 |
Passage | Immunology & Inflammation |
Background | Antipyrine is a selective COX3 inhibitor. |
Biological Activity | Antipyrine, an antipyretic and analgesic, has been given as ear drops and by mouth. Antipyrine is frequently used to test the effects of other diseases or drugs on drug-metabolizing enzymes in the liver.[1-2] |
Data Literature Source | [1] Kind PR,et al,J Clin Pathol,1954,7(4),322-326. [2] Soberman R,et al,J Biol Chem,1949,179(1),31-42. |
Unit | Bottle |
Specification | 10mg 10mM*1mL in DMSO 50mg 100mg |
是一种选择性COX3抑制剂。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.